Clopidogrel is an ADP receptor antagonist that is indicated for the reduction of
atherosclerotic events including myocardial infarction, ischaemic stroke and vascular death …

This review evaluates the quality of available administrative data in the Canadian provinces,
emphasizing the information needed to create integrated systems. We explicitly compare …

Background Preliminary reports of studies involving simple coronary lesions indicate that a
sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous …

Background—The importance of completeness of revascularization by percutaneous
coronary intervention in patients with multivessel disease is unclear in that there is little …

Background The platelet glycoprotein IIb/IIIa inhibitors, although effective in reducing
ischaemic complications of percutaneous coronary intervention, are used in few coronary …

Background—Although refinements have occurred in coronary angioplasty over the past
decade, little is known about whether these changes have affected outcomes. Methods and …

ContextWomen who present with acute coronary syndromes (ACSs) have different
characteristics than men. Reports have conflicted about whether different outcomes exist for …

Inflammation plays a pathogenic role in the development of restenosis after percutaneous
transluminal coronary angioplasty (PTCA). Monocyte chemoattractant protein-1 (MCP-1) is a …

Background—Recently, sirolimus-eluting stents (SESs) have been shown to dramatically
reduce the risk of angiographic and clinical restenosis compared with bare metal stent …

Objectives: The goal of this study was to determine whether women undergoing
contemporary percutaneous coronary intervention (PCI) remain at increased risk in …